Repligen (RGEN) Insider Trading & Ownership $138.90 +10.41 (+8.10%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Repligen (NASDAQ:RGEN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.20%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$449,938.10Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$12.38 M Get RGEN Insider Trade Alerts Want to know when executives and insiders are buying or selling Repligen stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RGEN Insider Buying and Selling by Quarter Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Repligen Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/10/2024Anthony HuntDirectorSell22,191$145.37$3,225,905.67 8/1/2024Ralf KuriyelVPSell4,465$165.67$739,716.55 6/14/2024Anthony HuntCEOBuy2,000$124.08$248,160.00 6/14/2024Martin D MadausDirectorBuy1,615$124.94$201,778.10 5/21/2024Anthony HuntCEOSell20,072$168.26$3,377,314.72 3/11/2024Ralf KuriyelVPSell3,517$193.73$681,348.41 3/8/2024Anthony HuntCEOSell16,707$197.44$3,298,630.08 2/27/2024Karen A DawesDirectorSell1,000$193.35$193,350.00 2/23/2024James BylundCOOSell4,373$198.08$866,203.84 (Data available from 1/1/2013 forward) RGEN Insider Trading Activity - Frequently Asked Questions Who is on Repligen's Insider Roster? The list of insiders at Repligen includes Anthony Hunt, Christine Gebski, James Bylund, Jon Snodgres, Karen A Dawes, Manner Carrie Eglinton, Martin D Madaus, Ralf Kuriyel, and Thomas F Ryan Jr. Learn more on insiders at RGEN. What percentage of Repligen stock is owned by insiders? 1.20% of Repligen stock is owned by insiders. Learn more on RGEN's insider holdings. Which Repligen insiders have been buying company stock? The following insiders have purchased RGEN shares in the last 24 months: Anthony Hunt ($248,160.00), and Martin D Madaus ($360,443.10). How much insider buying is happening at Repligen? Insiders have purchased a total of 4,615 RGEN shares in the last 24 months for a total of $608,603.10 bought. Which Repligen insiders have been selling company stock? The following insiders have sold RGEN shares in the last 24 months: Anthony Hunt ($9,901,850.47), Christine Gebski ($557,328.44), James Bylund ($866,203.84), Karen A Dawes ($339,023.00), and Ralf Kuriyel ($1,421,064.96). How much insider selling is happening at Repligen? Insiders have sold a total of 76,963 Repligen shares in the last 24 months for a total of $13,085,470.71 sold. Repligen Key ExecutivesMr. Anthony J. Hunt (Age 60)Executive Chair Compensation: $885k3 recent tradesMr. Olivier Loeillot (Age 54)President, CEO & Director Compensation: $1.49MMr. Jason K. Garland (Age 50)CFO & Chief Compliance Officer Compensation: $282.99kMr. James R. Bylund (Age 60)Chief Operating Officer Compensation: $472.18kMr. Ralf Kuriyel (Age 66)Senior Vice President of Research & Development Compensation: $401.74k1 recent tradesMr. Keith Lee RobinsonChief Information OfficerMs. Sondra S. NewmanGlobal Head of Investor RelationsMs. Kimberly A. CornwellGlobal Head of LegalMr. Neil WhitfieldVP & Global Head of SalesMs. Leslie GalvinVice President of Human Resources More Insider Trading Tools from MarketBeat Related Companies CRISPR Therapeutics Insider Trades Bio-Techne Insider Trades Denali Therapeutics Insider Trades Adaptive Biotechnologies Insider Trades Moderna Insider Trades Biogen Insider Trades United Therapeutics Insider Trades Incyte Insider Trades Neurocrine Biosciences Insider Trades BioMarin Pharmaceutical Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:RGEN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Repligen Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Repligen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
